Caroline Lundgren

969 total citations
18 papers, 696 citations indexed

About

Caroline Lundgren is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Caroline Lundgren has authored 18 papers receiving a total of 696 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Obstetrics and Gynecology, 8 papers in Reproductive Medicine and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Caroline Lundgren's work include Endometrial and Cervical Cancer Treatments (13 papers), Ovarian cancer diagnosis and treatment (8 papers) and Prostate Cancer Treatment and Research (5 papers). Caroline Lundgren is often cited by papers focused on Endometrial and Cervical Cancer Treatments (13 papers), Ovarian cancer diagnosis and treatment (8 papers) and Prostate Cancer Treatment and Research (5 papers). Caroline Lundgren collaborates with scholars based in Sweden, Germany and Italy. Caroline Lundgren's co-authors include Bengt Sorbe, Karin Boman, Håkan Andersson, Birgitta Pettersson, György Horváth, Gunnar B. Kristensen, Germana Tognon, Gennaro Cormio, Mauro Signorelli and Carlos Oliveira and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Caroline Lundgren

17 papers receiving 683 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Caroline Lundgren Sweden	9	593	501	106	81	65	18	696
Jennifer Ducie United States	13	436 0.7×	409 0.8×	120 1.1×	74 0.9×	54 0.8×	16	630
Matthew Cesari Canada	10	416 0.7×	332 0.7×	125 1.2×	72 0.9×	72 1.1×	19	529
Tsunehisa Kaku Japan	11	524 0.9×	534 1.1×	98 0.9×	91 1.1×	76 1.2×	11	698
R. Fossati Italy	8	479 0.8×	551 1.1×	63 0.6×	72 0.9×	179 2.8×	14	704
Tommaso Grassi Italy	12	231 0.4×	266 0.5×	76 0.7×	53 0.7×	58 0.9×	32	422
Diana Lim Singapore	11	211 0.4×	234 0.5×	56 0.5×	77 1.0×	58 0.9×	30	415
Francesca Vecchione Italy	9	327 0.6×	257 0.5×	151 1.4×	79 1.0×	135 2.1×	15	520
Brooke A. Schlappe United States	10	197 0.3×	255 0.5×	93 0.9×	135 1.7×	73 1.1×	17	425
Mary Kinloch Canada	7	247 0.4×	191 0.4×	69 0.7×	40 0.5×	78 1.2×	18	365
Audrey P. Garrett United States	9	230 0.4×	269 0.5×	29 0.3×	72 0.9×	83 1.3×	15	467

Countries citing papers authored by Caroline Lundgren

Since Specialization

Citations

This map shows the geographic impact of Caroline Lundgren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline Lundgren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline Lundgren more than expected).

Fields of papers citing papers by Caroline Lundgren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caroline Lundgren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline Lundgren. The network helps show where Caroline Lundgren may publish in the future.

Co-authorship network of co-authors of Caroline Lundgren

This figure shows the co-authorship network connecting the top 25 collaborators of Caroline Lundgren. A scholar is included among the top collaborators of Caroline Lundgren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caroline Lundgren. Caroline Lundgren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

1.

Mirza, Mansoor Raza, Mark S. Shahin, Matthew A. Powell, et al.. (2023). Patient-reported outcomes (PROs) in patients (pts) with primary advanced or recurrent endometrial cancer (pA/rEC) treated with dostarlimab (D) plus carboplatin/paclitaxel (CP) compared with CP in the ENGOT-EN6/GOG3031/RUBY trial.. JCO Oncology Practice. 19(11_suppl). 332–332. 1 indexed citations

2.

Mirza, Mansoor Raza, Matthew A. Powell, Caroline Lundgren, et al.. (2023). Patient-reported outcomes (PROs) in primary advanced or recurrent endometrial cancer (pA/rEC) for patients (pts) treated with dostarlimab plus carboplatin/paclitaxel (CP) as compared to CP in the ENGOT-EN6/GOG3031/RUBY trial.. Journal of Clinical Oncology. 41(16_suppl). 5504–5504. 3 indexed citations

3.

Mirza, Mansoor Raza, Dominique Berton, Ignace Vergote, et al.. (2021). 1196 A randomised phase II study of combination chemotherapy with nintedanib/placebo in advanced/recurrent endometrial cancer. FANDANGO/ENGOT-EN1/FANDANGO. A371.2–A372. 5 indexed citations

4.

Mirza, Mansoor Raza, Caroline Lundgren, Frédéric Kridelka, et al.. (2017). Postoperative chemotherapy or no further treatment for patients with node-negative stage I-II intermediate or high risk endometrial cancer: The ENGOT-EN2/DGCG trial.. Journal of Clinical Oncology. 35(15_suppl). TPS5613–TPS5613. 6 indexed citations

5.

Mirza, Mansoor Raza, Caroline Lundgren, Frédéric Kridelka, Annamaria Ferrero, & Frédéric Amant. (2014). A phase III trial of postoperative chemotherapy or no further treatment for patients with node-negative stage I-II intermediate- or high-risk endometrial cancer. ENGOT-EN2-DGCG/EORTC 55102.. Journal of Clinical Oncology. 32(15_suppl). TPS5628–TPS5628. 1 indexed citations

6.

Amant, Frédéric, Caroline Lundgren, Frédéric Kridelka, et al.. (2014). A Phase III Trial of Postoperative Chemotherapy or No Further Treatment for Patients with Node- Negative Stage I-Ii Intermediate or High Risk Endometrial Cancer. Engot-En2-Dgcg / Eortc 55102. Annals of Oncology. 25. iv324–iv324. 1 indexed citations

7.

Lomnytska, Marta, Susanne Becker, Timo Gemoll, et al.. (2012). Impact of genomic stability on protein expression in endometrioid endometrial cancer. British Journal of Cancer. 106(7). 1297–1305. 31 indexed citations

8.

Sorbe, Bengt, György Horváth, Håkan Andersson, et al.. (2012). External Pelvic and Vaginal Irradiation Versus Vaginal Irradiation Alone as Postoperative Therapy in Medium-Risk Endometrial Carcinoma. International Journal of Gynecological Cancer. 22(7). 1281–1288. 42 indexed citations

9.

Gemoll, Timo, Jens K. Habermann, Silke Szymczak, et al.. (2011). Protein profiling of genomic instability in endometrial cancer. Cellular and Molecular Life Sciences. 69(2). 325–333. 7 indexed citations

10.

Habermann, Jens K., Timo Gemoll, Sampsa Hautaniemi, et al.. (2011). Genomic instability influences the transcriptome and proteome in endometrial cancer subtypes. Molecular Cancer. 10(1). 132–132. 18 indexed citations

11.

Sorbe, Bengt, György Horváth, Håkan Andersson, et al.. (2011). External Pelvic and Vaginal Irradiation Versus Vaginal Irradiation Alone as Postoperative Therapy in Medium-Risk Endometrial Carcinoma—A Prospective Randomized Study. International Journal of Radiation Oncology*Biology*Physics. 82(3). 1249–1255. 110 indexed citations

12.

Högberg, Thomas, Mauro Signorelli, Carlos Oliveira, et al.. (2010). Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer – Results from two randomised studies. European Journal of Cancer. 46(13). 2422–2431. 313 indexed citations

13.

Högberg, Thomas, P. Rosenberg, Gunnar B. Kristensen, et al.. (2007). A randomized phase-III study on adjuvant treatment with radiation (RT) ± chemotherapy (CT) in early-stage high-risk endometrial cancer (NSGO-EC-9501/EORTC 55991). Journal of Clinical Oncology. 25(18_suppl). 5503–5503. 80 indexed citations

14.

Lundgren, Caroline, et al.. (2006). 2-DE protein expression in endometrial carcinoma. Acta Oncologica. 45(6). 685–694. 3 indexed citations

15.

Lundgren, Caroline, Gert Auer, B. Frankendal, Bo Nilsson, & Britta Nordström. (2004). Prognostic factors in surgical stage I endometrial carcinoma. Acta Oncologica. 43(1). 49–56. 22 indexed citations

16.

Lundgren, Caroline, B. Frankendal, Claes Silfverswärd, et al.. (2003). Laminin-5 γ2-Chain Expression and DNA Ploidy as Predictors of Prognosis in Endometrial Carcinoma. Medical Oncology. 20(2). 147–156. 8 indexed citations

17.

Lundgren, Caroline, et al.. (2002). Nuclear DNA content, proliferative activity, and p53 expression related to clinical and histopathologic features in endometrial carcinoma. International Journal of Gynecological Cancer. 12(1). 110–118. 37 indexed citations

18.

Lundgren, Caroline, et al.. (2002). Nuclear DNA content, proliferative activity, and p53 expression related to clinical and histopathologic features in endometrial carcinoma. International Journal of Gynecological Cancer. 12(1). 110–118. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact